Compare VEEV & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VEEV | RJF |
|---|---|---|
| Founded | 2007 | 1962 |
| Country | United States | United States |
| Employees | 7928 | N/A |
| Industry | Computer Software: Prepackaged Software | Investment Bankers/Brokers/Service |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.2B | 32.5B |
| IPO Year | 2013 | N/A |
| Metric | VEEV | RJF |
|---|---|---|
| Price | $172.37 | $141.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 26 | 11 |
| Target Price | ★ $283.80 | $182.91 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 03-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | ★ 25.93 | N/A |
| EPS | ★ 5.44 | N/A |
| Revenue | ★ $1,104,081,000.00 | N/A |
| Revenue This Year | $14.26 | $14.81 |
| Revenue Next Year | $11.80 | $8.22 |
| P/E Ratio | $32.87 | ★ $15.77 |
| Revenue Growth | ★ 28.05 | N/A |
| 52 Week Low | $168.14 | $118.57 |
| 52 Week High | $310.50 | $177.66 |
| Indicator | VEEV | RJF |
|---|---|---|
| Relative Strength Index (RSI) | 34.13 | 31.84 |
| Support Level | $169.92 | N/A |
| Resistance Level | $184.71 | $169.06 |
| Average True Range (ATR) | 6.16 | 3.06 |
| MACD | -0.63 | 0.16 |
| Stochastic Oscillator | 3.75 | 9.50 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.